{"id":475848,"date":"2020-03-24T14:52:01","date_gmt":"2020-03-24T14:52:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=475848"},"modified":"2020-03-24T14:52:01","modified_gmt":"2020-03-24T14:52:01","slug":"peanut-allergy-market-insights-epidemiology-and-market-forecast-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/peanut-allergy-market-insights-epidemiology-and-market-forecast-2030_475848.html","title":{"rendered":"Peanut Allergy Market Insights, Epidemiology, and Market Forecast 2030"},"content":{"rendered":"
\"Peanut<\/a><\/div>\n

(Albany, US) DelveInsight has launched a new report on Peanut Allergy Market Insights, Epidemiology and Market Forecast-2030<\/strong><\/p>\n

DelveInsight’s “Peanut Allergy – Market Insights, Epidemiology, and Market Forecast-2030″<\/span> report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as the Peanut Allergy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

The Peanut Allergy market report provides current treatment practices, emerging drugs, Peanut Allergy market share of the individual therapies, current and forecasted Peanut Allergy market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Peanut Allergy treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.<\/p>\n

Food allergy is an abnormal response to a food triggered by the body’s immune system. There are several types of immune response to food. A peanut allergy is an allergic reaction to peanuts which occurs when the human body mistakenly identifies peanuts as harmful substances. Peanut allergy is recognized as one of the most severe food allergies due to its prevalence, persistency, and the potential severity of the allergic reaction. Although other food allergies occurring in childhood usually resolve
spontaneously with age, peanut sensitivity appears early in life and often persists indefinitely. Frequently, large quantities of peanut allergens are not needed to elicit an allergic reaction- even trace levels of peanut are capable of causing a hypersensitive reaction.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

Request for :- Peanut Allergy free sample page<\/a><\/strong><\/p>\n

 <\/p>\n

Peanut Allergy Epidemiology<\/strong><\/p>\n

The Peanut Allergy epidemiology division provide insights about historical and current Peanut Allergy patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  <\/p>\n

Report Key facts:- <\/strong> <\/p>\n

1. The prevalence has increased steadily over the past decade, mostly in the Western world. As per
DelveInsight estimates, total prevalent population of Peanut Allergy in the 7MM was found to be 8,640,527
in 2017. The estimates show higher prevalence is in the US with 4,659,471 cases in 2017 and is a growing
health problem in US, specifically in children.<\/p>\n

2. Among the EU5 countries, France had the highest prevalent population of Peanut Allergy with 614,959 cases, followed by Germany and the United Kingdom.<\/p>\n

3. As per DelveInsight analysis, it is observed that, Japan has the least number of prevalent cases (1,548,318 for 2017) of Peanut Allergy, among the 7MM.<\/p>\n

 <\/p>\n

Peanut and tree nut allergy is most common in infants and younger children, but may appear for the first time in adults and is long lasting. Peanut allergy often receives greater attention because it is common (3% of infants), exposure is hard to avoid and in some cases even trace amounts can trigger symptoms. Around 20% of cases resolve, and while severity may occasionally lessen with age, around 20% of cases can become worse with time.<\/strong><\/em><\/p>\n

Key companies working on peanut allergy are given below:- <\/strong><\/em><\/p>\n

1. <\/strong>Aimmune Therapeutics Pharma Co.<\/em><\/p>\n

2. DBV Technologies<\/em><\/p>\n

Name of drugs covered that are given below:- <\/em><\/strong><\/p>\n

1. Technologies<\/p>\n

2. Technologies<\/p>\n

 <\/p>\n

Table of Content<\/strong><\/p>\n

1. Key Insights<\/span><\/p>\n

2. Executive Summary of Peanut Allergy<\/span><\/p>\n

3. Competitive Intelligence Analysis for Peanut Allergy<\/span><\/p>\n

4. Peanut Allergy: Market Overview at a Glance<\/span><\/p>\n

4.1. Peanut Allergy Total Market Share (%) Distribution in 2017<\/span><\/p>\n

4.2. Peanut Allergy Total Market Share (%) Distribution in 2030<\/span><\/p>\n

5. Peanut Allergy: Disease Background and Overview<\/span><\/p>\n

5.1. Introduction<\/span><\/p>\n

5.2. Sign and Symptoms <\/span><\/p>\n

5.3. Pathophysiology <\/span><\/p>\n

5.4. Risk Factors <\/span><\/p>\n

5.5. Diagnosis <\/span><\/p>\n

6. Patient Journey<\/span><\/p>\n

7. Peanut Allergy Epidemiology and Patient Population<\/span><\/p>\n

7.1. Epidemiology Key Findings<\/span><\/p>\n

7.2. Assumptions and Rationale: 7MM<\/span><\/p>\n

7.3. Epidemiology Scenario: 7MM<\/span><\/p>\n

7.3.1. Peanut Allergy Epidemiology Scenario in the 7MM (2017-2030)<\/span><\/p>\n

7.4. United States Epidemiology<\/span><\/p>\n

7.4.1. Peanut Allergy Epidemiology Scenario in the United States (2017-2030)<\/span><\/p>\n

7.5. EU-5 Country-wise Epidemiology<\/span><\/p>\n

7.5.1. Germany Epidemiology<\/span><\/p>\n

7.5.1.1. Peanut Allergy Epidemiology Scenario in Germany (2017-2030)<\/span><\/p>\n

7.5.2. France Epidemiology<\/span><\/p>\n

7.5.2.1. Peanut Allergy Epidemiology Scenario in France (2017-2030)<\/span><\/p>\n

7.5.3. Italy Epidemiology<\/span><\/p>\n

7.5.3.1. Peanut Allergy Epidemiology Scenario in Italy (2017-2030)<\/span><\/p>\n

7.5.4. Spain Epidemiology<\/span><\/p>\n

7.5.4.1. Peanut Allergy Epidemiology Scenario in Spain (2017-2030)<\/span><\/p>\n

7.5.5. United Kingdom Epidemiology<\/span><\/p>\n

7.5.5.1. Peanut Allergy Epidemiology Scenario in the United Kingdom (2017-2030)<\/span><\/p>\n

7.5.6. Japan Epidemiology<\/span><\/p>\n

7.5.6.1. Peanut Allergy Epidemiology Scenario in Japan (2017-2030)<\/span><\/p>\n

8. Treatment Algorithm, Current Treatment, and Medical Practices<\/span><\/p>\n

8.1. Peanut Allergy Treatment and Management<\/span><\/p>\n

8.2. Peanut Allergy Treatment Algorithm <\/span><\/p>\n

9. Unmet Needs<\/span><\/p>\n

10. Key Endpoints of Peanut Allergy Treatment<\/span><\/p>\n

11. Marketed Products<\/span><\/p>\n

11.1. List of Marketed Products in the 7MM<\/span><\/p>\n

11.2. Drug Name: Company Name<\/span><\/p>\n

11.2.1. Product Description<\/span><\/p>\n

11.2.2. Regulatory Milestones<\/span><\/p>\n

11.2.3. Other Developmental Activities<\/span><\/p>\n

11.2.4. Pivotal Clinical Trials<\/span><\/p>\n

11.2.5. Summary of Pivotal Clinical Trial<\/span><\/p>\n

List to be continued in report<\/span><\/p>\n

12. Emerging Therapies<\/span><\/p>\n

12.1. Key Cross<\/span><\/p>\n

12.2. Drug Name: Company Name<\/span><\/p>\n

12.2.1. Product Description<\/span><\/p>\n

12.2.2. Other Developmental Activities<\/span><\/p>\n

12.2.3. Clinical Development<\/span><\/p>\n

12.2.4. Safety and Efficacy<\/span><\/p>\n

12.2.5. Product Profile<\/span><\/p>\n

List to be continued in report<\/span><\/p>\n

13. Peanut Allergy: Seven Major Market Analysis<\/span><\/p>\n

13.1. Key Findings<\/span><\/p>\n

13.2. Peanut Allergy Market Size in 7MM<\/span><\/p>\n

13.3. Peanut Allergy Market Size by Therapies in the 7MM<\/span><\/p>\n

14. Attribute analysis<\/span><\/p>\n

15. 7MM: Market Outlook<\/span><\/p>\n

15.1. United States: Market Size<\/span><\/p>\n

15.1.1. Peanut Allergy Total Market Size in the United States<\/span><\/p>\n

15.1.2. Peanut Allergy Market Size by Therapies in the United States<\/span><\/p>\n

15.2. EU-5 countries: Market Size and Outlook<\/span><\/p>\n

15.3. Germany Market Size<\/span><\/p>\n

15.3.1. Peanut Allergy Total Market Size in Germany<\/span><\/p>\n

15.3.2. Peanut Allergy Market Size by Therapies in Germany<\/span><\/p>\n

15.4. France Market Size<\/span><\/p>\n

15.4.1. Peanut Allergy Total Market Size in France<\/span><\/p>\n

15.4.2. Peanut Allergy Market Size by Therapies in France<\/span><\/p>\n

15.5. Italy Market Size<\/span><\/p>\n

15.5.1. Peanut Allergy Total Market Size in Italy<\/span><\/p>\n

15.5.2. Peanut Allergy Market Size by Therapies in Italy<\/span><\/p>\n

15.6. Spain Market Size<\/span><\/p>\n

15.6.1. Peanut Allergy Total Market Size in Spain<\/span><\/p>\n

15.6.2. Peanut Allergy Market Size by Therapies in Spain<\/span><\/p>\n

15.7. United Kingdom Market Size<\/span><\/p>\n

15.7.1. Peanut Allergy Total Market Size in the United Kingdom<\/span><\/p>\n

15.7.2. Peanut Allergy Market Size by Therapies in the United Kingdom<\/span><\/p>\n

15.8. Japan Market Outlook<\/span><\/p>\n

15.8.1. Japan Market Size<\/span><\/p>\n

15.8.2. Peanut Allergy Total Market Size in Japan<\/span><\/p>\n

15.8.3. Peanut Allergy Market Size by Therapies in Japan<\/span><\/p>\n

16. Access and Reimbursement Overview of Peanut Allergy<\/span><\/p>\n

17. KOL Views<\/span><\/p>\n

18. Market Drivers<\/span><\/p>\n

19. Market Barriers<\/span><\/p>\n

20. Appendix<\/span><\/p>\n

20.1. Bibliography<\/span><\/p>\n

20.2. Report Methodology<\/span><\/p>\n

21. DelveInsight Capabilities<\/span><\/p>\n

22. Disclaimer<\/span><\/p>\n

23. About DelveInsight<\/a><\/strong><\/p>\n

 <\/p>\n

Why should you buy this report ?<\/strong><\/p>\n